Generate Biomedicines, Inc.(GENB:US)
Market Cap$1.55B
Key Metrics
Price$12.09
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$160.58M
Total Assets$625.74M
Net Assets$514.8M
Total Debt$65.57M
Key Metrics
Price$12.09
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$160.58M
Total Assets$625.74M
Net Assets$514.8M
Total Debt$65.57M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $7.22M | $8.82M |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $71.34M | $56.97M | |
| Research and Development | $57.81M | $46.83M |
| Selling, General, and Administrative | $13.52M | $10.15M |
| Other Operating Expenses | - | - |
Operating Income | -$64.11M | -$48.15M |
| $2.43M | $3.9M | |
| Non-Operating Interest Income | $2.91M | $4.28M |
| Non-Operating Interest Expense | $182K | $368K |
| Other Income/Expense | -$305K | -$17K |
Income Before Tax | -$61.69M | -$44.26M |
Income Tax | $28K | $56K |
Net Income | -$61.71M | -$44.31M |
Minority Interests | $268K | $2.63M |
Preferred Stock Dividends | - | - |
Net Income to Common | -$61.45M | -$41.69M |
Shares Outstanding (Basic) | 64.87M | 102.31M |
Shares Outstanding (Diluted) | 64.87M | 102.31M |
EPS (Basic) | -$1.07 | -$0.52 |
EPS (Diluted) | -$1.07 | -$0.52 |
EBIT | -$61.5M | -$43.89M |
EBITDA | -$57.93M | -$40.46M |